N4 Pharma Share Discussion Threads

[whl2] 17/10/2017 16:30

Not exactly rocketing jakleeds, will be back down to 6p tomorrow knowing the mm's

[sharesoc] 17/10/2017 15:54

N4 Pharma have joined the line up for our next London seminar on the 8th November: Join us for presentations and a chance to ask questions to management.

[jakleeds] 17/10/2017 13:12

Nice reversal - chart looks ripe for a massive breakout imo

[timbo003] 10/10/2017 23:27

Published patent application referred to in the RNS is here for anyone who is interested:

[trotterstrading] 10/10/2017 15:18

Idiots selling at a loss rather than wait a few months for transformational patient studies to begin?! No wonder 80% of AIM punters lose money

[jakleeds] 10/10/2017 08:07

Nice update. Massive potential here, not without risk of course.

[photon] 10/10/2017 07:53

Having only looked briefly at N4P before, I wasn't aware of the market research they quote today. Those percentages of clinicians potentially prepared to switch to N4P's formulation, particularly in the US, are higher than I would have expected. Very interesting, if they can get this to market.

[parob] 10/10/2017 07:15

Nigel Theobald, CEO of N4 Pharma, commented: "The publication of the Patent Application marks another important step in our lead product sildenafil as we head towards our initial human pilot clinical trials within the next few months. With the Patent Application now formally published, we can talk more freely with investors and other interested parties about what our reformulated sildenafil will hope to achieve in terms of its pharmacokinetic properties and where it might sit amongst competitors in this highly lucrative market."

[jakleeds] 06/10/2017 09:36

Yep. Some interest here today ...

[escapetohome] 06/10/2017 09:14

V shaped bowl formation.

BOWL.

[jakleeds] 06/10/2017 09:10

Chart curving nicely upwards here. Risky, but could be an absolute cracker imo

[backtogo] 25/9/2017 20:10

sufficient cash for admin expenses only looking at them. not getting any product to market. cash call soon!!

[backtogo] 25/9/2017 20:04

LOLthat's why nobody takes any notice of you

[flashheart] 25/9/2017 20:01

Rule 1 on the boards TT......never engage with a bell end!

[trotterstrading] 25/9/2017 19:33

Read the results Backtogo ffs! Sufficient cash for 2017 and 2018!

[backtogo] 25/9/2017 10:51

Burnt 200k in 2 month?Fair to assume that cash burn was higher immediately after listing. But even at 100k + the current cash will be gone within a year.Better get a product to market fast. Or suffer dilution.

[biggest bill] 15/9/2017 09:57

I can only buy 5000 shares online but I can sell 150000. Perhaps there is something happening in the background?

[backtogo] 12/9/2017 11:08

Still not worth a punt here. Early birds are being flushed.Not until the whopping cash call. It will come, probably after a positive RNS about one of the products, and a small spike in the price.Maybe then it's worth gambling your beer money on.3p- I think.

[parob] 05/9/2017 07:24

Sorry for O/T again guys but take a look at OPTI. They've just struck a deal with Tata Chemicals!

[top tips] 01/9/2017 09:24

IMMUPHARMA (IMM)

Potential blockbuster Lupuzor Phase III results due Q1 2018.

Only other similar drug Benlysta was bought out from HGSi by GSK in 2012 for $3.6 billion for 50% stake valuing Benlysta around $7 billion (and IMM's Lupuzor appears to be safer and more efficaceous than Benlysta).

$7 billion buyout of IMM gives £39.70 share price against current 49p, or 80 bagger !!!

Potential blockbuster Lupuzor has 'Fast Track' and 'SPA' status from US FDA, so could market launched in 2018.

Tim McCarthy (IMM's Chairman) 14/3/2017:

"There's going to be a fantastic return on investment for anybody who invests in ImmuPharma...This (Lupuzor) is going to be a multi-billion dollar drug, its as simple as that...This will absolutely be a multi-billion dollar drug."

4 min 40 sec.

[zebbo] 28/8/2017 17:16

Opti & n4p are my banks over the next 12 to 18 months. Both have yet to spread there wings

[parob] 24/8/2017 12:09

Another 127K for me.OPTI still rising guys...

[parob] 23/8/2017 19:29

If this drops to 5.75p on the offer I'm having a load more.Worth taking a gander at OPTI folks.

[square root] 23/8/2017 14:36

I see that Flexton has been outed as the troll Slopjockey who posts on lse about n4p. Both Flexton and Slopjockey have said that they would stop posting comments on n4p but just can't help himself. Obviously someone with a personal grudge about n4p.